Ticker Symbol: SBTX

Silverback Therapeutics Inc

$8.52 - 20-12-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001671858

Company Profile

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: silverbacktx.com

CEO: N/A

Tags: N/A

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: $5.72 - $6.15

Beta: 1.02

52wk. High: $8.97

52wk. Low: $2.80

Ytd. Change -11.86%

50 Day Moving Average: $5.50

200 Day Moving Average: $4.61

Shares Outstanding: 36058338

Valuation

Market Cap: 21.9B

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A